DisclosureWe earn commission on partner links; ranking is set by our evidence-based methodology — not advertisers. Read policy
Reviewed by the HealthVetted Editorial
Type 2 diabetes is a long-term condition in which the body either resists the effect of insulin or doesn't make enough of it, so glucose (sugar) builds up in the blood instead of fueling cells. It is the most common form of diabetes, develops gradually over years, and — caught early — can often be slowed, well-controlled, and in some cases pushed into remission.
Insulin is a hormone made by the pancreas that acts like a key, letting glucose move out of the bloodstream and into cells to be used for energy or stored. In type 2 diabetes, two problems usually occur together: the body's cells stop responding normally to insulin (insulin resistance), and over time the pancreas can no longer produce enough insulin to overcome that resistance (beta-cell dysfunction). The result is chronically elevated blood glucose, known as hyperglycemia (NIH; StatPearls).
This is different from type 1 diabetes, an autoimmune disease in which the immune system destroys the insulin-producing cells and the body makes little or no insulin at all. Type 2 accounts for the large majority of diabetes cases — roughly 90–95% — and is strongly linked to body weight, activity, genetics, and age, though it can occur in people of any size (CDC; ADA).
Type 2 diabetes is also a progressive condition that often begins silently. For years beforehand, many people pass through prediabetes, a stage where blood sugar is higher than normal but not yet in the diabetic range. According to the CDC, the great majority of people with prediabetes don't know they have it, which is why screening matters so much.
In medical records, type 2 diabetes is coded under ICD-10 E11, with additional digits specifying complications (for example, E11.9 for type 2 diabetes without complications, or E11.65 with hyperglycemia). Prediabetes is coded as R73.03.
Type 2 diabetes develops from a combination of genetic susceptibility and modifiable lifestyle and body-composition factors. The central mechanism most researchers emphasize is the accumulation of excess fat where it does not belong — particularly visceral fat around the abdominal organs and fat deposited inside the liver and muscle. This ectopic fat releases free fatty acids and inflammatory signals that interfere with insulin's action, driving the insulin resistance at the heart of the disease (StatPearls; NIH).
Major risk factors include:
The ADA recommends screening all adults beginning at age 35, and earlier in those who are overweight or obese and have one or more additional risk factors (ADA Standards of Care). Importantly, type 2 diabetes is not exclusive to people with obesity; lean individuals with significant insulin resistance can develop it too, often reflecting where fat is stored rather than total body weight.
Because blood sugar rises gradually, type 2 diabetes often produces few or no symptoms in its early stages, and many people are diagnosed through routine blood work before they ever feel unwell. When symptoms do appear, they tend to reflect elevated glucose and include:
A more specific visible clue can be acanthosis nigricans — velvety, darkened patches of skin in the neck folds, armpits, or groin — which is linked to the high insulin levels of insulin resistance (StatPearls; AAD). Because symptoms are subtle and easy to dismiss, clinicians emphasize screening high-risk people rather than waiting for complaints.
Diagnosis is based on blood tests that measure glucose, interpreted against thresholds set by the American Diabetes Association (ADA). Per the ADA Standards of Care in Diabetes, diabetes can be diagnosed by any of the following (ADA):
In the absence of unequivocal hyperglycemia, a diagnosis generally requires two abnormal test results — either two of the same test on different days, or two different abnormal tests from the same sample (ADA).
Prediabetes is defined by intermediate values (ADA):
A1C offers practical advantages — no fasting required, greater stability, and less day-to-day variation from stress, illness, or recent meals — but it can be unreliable in certain conditions such as some anemias, hemoglobin variants, pregnancy, or recent blood loss, where glucose-based testing is preferred (ADA). After diagnosis, doctors typically also check kidney function, cholesterol, blood pressure, and perform eye and foot exams to screen for complications.
Treatment follows a clear hierarchy and is increasingly individualized. The goals are to bring blood glucose into a safe range, protect the heart and kidneys, manage related risk factors, and prevent complications. Many people use a combination of lifestyle change and one or more medications.
Lifestyle modification is recommended for everyone with type 2 diabetes and is powerful on its own, especially early. The landmark Diabetes Prevention Program (DPP) showed that intensive lifestyle change — aiming for about 7% weight loss and 150 minutes of weekly activity — reduced progression from prediabetes to type 2 diabetes substantially, and outperformed medication (NIH; ADA). Core elements include:
There is no OTC medication that treats type 2 diabetes, and supplements should not replace prescribed therapy. Useful OTC tools center on supporting lifestyle and monitoring: home glucose meters and test strips, well-fitting footwear and foot-care supplies (to prevent ulcers), and a daily low-dose aspirin only when specifically recommended by a clinician for cardiovascular protection. Some supplements (such as cinnamon, berberine, or chromium) are marketed for blood sugar, but the evidence is limited and inconsistent, and they can interact with medications — discuss any with a doctor before use.
Several real drug classes are used, often in combination, and choice increasingly depends on a person's heart and kidney health rather than blood sugar alone (ADA Standards of Care):
Because the field is moving toward protecting organs, current ADA guidance emphasizes choosing agents like SGLT2 inhibitors and GLP-1 receptor agonists for people with heart or kidney disease, with or without metformin (ADA). All medication decisions should be individualized with a clinician.
For prevention, the evidence is strong and encouraging. In people with prediabetes, structured lifestyle programs — the basis of the CDC's National Diabetes Prevention Program — can substantially lower the risk of developing type 2 diabetes; in the DPP, lifestyle change reduced new cases more effectively than medication (CDC; NIH). Metformin is sometimes used preventively in higher-risk individuals.
For those already diagnosed, long-term management is about consistency and protecting against complications. That means keeping blood glucose, blood pressure, and cholesterol within target ranges; attending regular eye, kidney, and foot screenings; staying up to date on vaccinations; and addressing weight, activity, and smoking. The concept of diabetes remission — sustained normal blood sugar without glucose-lowering medication — is now recognized and is most achievable through significant weight loss, particularly within the first few years after diagnosis. Remission is not the same as cure; ongoing monitoring is still needed.
See a healthcare provider if you have risk factors and have not been screened, or if you notice symptoms such as increased thirst, frequent urination, persistent fatigue, blurred vision, slow-healing sores, or numbness and tingling in the hands or feet. People who already have diabetes should seek prompt care for foot wounds, infections, or blood sugar readings that are consistently outside their target range.
Certain symptoms are medical emergencies. Seek immediate care for signs of dangerously high blood sugar or its complications, including confusion, very rapid or deep breathing, fruity-smelling breath, severe abdominal pain, persistent vomiting, or extreme drowsiness. For people on insulin or sulfonylureas, severe low blood sugar (hypoglycemia) — with shakiness, sweating, confusion, or loss of consciousness — also requires urgent treatment.
With modern care, the outlook for type 2 diabetes is generally good, and many people live long, full lives. Well-controlled blood sugar, blood pressure, and cholesterol dramatically lower the risk of the most serious complications, which include heart disease and stroke, kidney disease, nerve damage (neuropathy), vision loss (retinopathy), and foot problems that can lead to amputation (CDC; NIH).
Because type 2 diabetes is progressive, treatment often needs to evolve over time, and medication needs may increase. But the trajectory is far from fixed: early diagnosis, sustained lifestyle change, weight management, and newer medications with proven heart and kidney benefits have meaningfully improved long-term outcomes. The central message is one of agency — the daily choices and consistent monitoring that manage type 2 diabetes also protect the heart, kidneys, and overall longevity.
Can type 2 diabetes be reversed or cured? There is no permanent cure, but type 2 diabetes can sometimes enter remission, meaning normal blood sugar without glucose-lowering medication. This is most achievable through substantial, sustained weight loss — especially within the first few years after diagnosis — and is more likely the earlier it is pursued. Remission still requires ongoing monitoring, because the condition can return.
What's the difference between type 1 and type 2 diabetes? Type 1 is an autoimmune disease in which the body destroys its insulin-producing cells and makes little or no insulin; it usually appears in childhood or young adulthood and always requires insulin. Type 2 involves insulin resistance plus a gradual decline in insulin production, develops mostly in adults (though increasingly in younger people), and is strongly tied to weight, activity, and genetics.
Is prediabetes the same as diabetes? No. Prediabetes means blood sugar is higher than normal but below the diabetic threshold (A1C 5.7–6.4%, or fasting glucose 100–125 mg/dL). It is a warning stage and a major risk factor for type 2 diabetes, but it is often reversible. Lifestyle change at this stage is highly effective at preventing progression (CDC; ADA).
Do I have to take insulin if I have type 2 diabetes? Not necessarily. Many people manage type 2 diabetes with lifestyle change and oral or non-insulin injectable medications. Insulin is added when other treatments aren't enough or blood sugar is very high. Needing insulin is not a personal failure — it reflects the progressive nature of the disease and the goal of keeping blood sugar safely controlled.
What A1C number means I have diabetes? An A1C of 6.5% or higher meets the diagnostic threshold for diabetes; 5.7%–6.4% indicates prediabetes; and below 5.7% is considered normal (ADA). Diagnosis usually requires a confirmatory test unless there are clear symptoms of high blood sugar. A1C can be misleading in some conditions, so doctors may rely on glucose-based tests instead.
*This page is for general education and is not medical advice. Talk to a qualified healthcare professional about diagnosis and treatment decisions specific to you.*
Several FDA-approved medication classes treat type 2 diabetes, and treatment is individualized by a clinician. Metformin (a biguanide) is a long-standing, low-cost first-line option. GLP-1 receptor agonists (for example, semaglutide/Ozempic and dulaglutide/Trulicity) and the dual GIP/GLP-1 agonist tirzepatide (Mounjaro) lower blood sugar, support weight loss, and several have proven cardiovascular benefit. SGLT2 inhibitors (for example, empagliflozin/Jardiance and dapagliflozin/Farxiga) lower glucose and have demonstrated heart-failure and kidney-protective benefits. Other approved classes include DPP-4 inhibitors, sulfonylureas, thiazolidinediones, and insulin. Current American Diabetes Association Standards of Care emphasize choosing therapy based on each person's cardiovascular and kidney risk, weight goals, and other health factors—not on glucose numbers alone. Only a licensed clinician can prescribe these medications; do not start, stop, or change any medication without medical guidance.
Type 2 diabetes cannot currently be cured, but many people can achieve remission, meaning blood sugar returns to a non-diabetic range without glucose-lowering medication. A 2021 consensus from the American Diabetes Association defines remission as an HbA1c below 6.5% sustained for at least three months after stopping diabetes drugs, most often achieved through substantial weight loss via low-calorie or low-carbohydrate eating or bariatric surgery. Remission is not guaranteed to be permanent, since diabetes can return if weight is regained, so ongoing monitoring with your clinician is essential.
Type 2 diabetes develops when the body's cells stop responding properly to insulin (insulin resistance) and the pancreas can no longer make enough insulin to keep blood sugar in a normal range. It results from a combination of factors including excess body weight, physical inactivity, and genetics or family history. Other contributors include older age, certain ethnic backgrounds, polycystic ovary syndrome (PCOS), and a history of gestational diabetes; only a clinician can confirm a diagnosis through blood testing.
Common symptoms of type 2 diabetes include increased thirst, frequent urination, fatigue, blurred vision, slow-healing cuts, and unintended weight changes. Symptoms often develop gradually over years, and many people have no noticeable symptoms in the early stages, which is why diabetes is sometimes found only through routine blood tests. A skin change called acanthosis nigricans (dark, velvety patches, often on the neck) can also signal insulin resistance, so any persistent symptoms should be evaluated by a healthcare provider.
Diabetes is diagnosed when an HbA1c is 6.5% or higher, a fasting plasma glucose is 126 mg/dL (7.0 mmol/L) or higher, or a 2-hour oral glucose tolerance test reads 200 mg/dL (11.1 mmol/L) or higher, per American Diabetes Association criteria. A random glucose of 200 mg/dL or higher with classic symptoms also qualifies. Apart from a clear hyperglycemic crisis, results are usually confirmed with a repeat or second test, so diagnosis should always be made by a clinician.
Prediabetes means blood sugar is higher than normal but not yet high enough to be diabetes, defined as an HbA1c of 5.7% to 6.4%, a fasting glucose of 100 to 125 mg/dL, or a 2-hour glucose of 140 to 199 mg/dL. It is a major risk factor for progressing to type 2 diabetes, but progression is not inevitable. Lifestyle changes such as modest weight loss and regular physical activity can substantially lower the risk of developing diabetes; talk to your clinician about screening and a prevention plan.
Treatment combines lifestyle changes, such as a balanced diet, regular physical activity, and weight management, with medications when needed. Metformin is a common first-line drug, while GLP-1 receptor agonists and SGLT2 inhibitors are increasingly used because they can also lower the risk of cardiovascular and kidney complications. Some people eventually need insulin; because the best plan depends on your overall health, treatment should be individualized with your healthcare provider.
Type 2 diabetes is influenced by both genetics and lifestyle, not one alone. A family history of diabetes raises your risk, but factors such as excess weight, diet, and physical inactivity strongly affect whether and when the condition develops. This means the inherited risk can often be reduced through lifestyle measures, and people with a family history should ask their clinician about earlier or more frequent screening.
Independent, evidence-based reviews — not paid placements. See our full analysis:
This page is for general information and is not medical advice. Always consult a qualified clinician about diagnosis and treatment. Individual results vary.